Literature DB >> 6389330

Neuroblastoma.

S C Gulati, R Vega, L Gandola, C Gulati, J Yopp, R O'Reilly, B Clarkson.   

Abstract

Entities:  

Mesh：

Year:  1983        PMID： 6389330     DOI： 10.1007/bf02957736

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  9 in total

1.  Correlation of cell kinetic and clinical response to chemotherapy in disseminated neuroblastoma.

Authors:  F A Hayes; A A Green; A M Mauer
Journal:  Cancer Res       Date:  1977-10       Impact factor: 12.701

2.  Multiagent chemotherapy for children with metastatic neuroblastoma: a report from Childrens Cancer Study Group.

Authors:  J Z Finklestein; M R Klemperer; A Evans; I Bernstein; S Leikin; S McCreadie; J Grosfeld; R Hittle; J Weiner; H Sather; D Hammond
Journal:  Med Pediatr Oncol       Date:  1979

3.  Sequential hemi-body irradiation (HBI) in treatment of advanced neuroblastoma: a pilot study.

Authors:  L Helson; B Jereb; R Vogel
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-04       Impact factor: 7.038

4.  A proposed staging for children with neuroblastoma. Children's cancer study group A.

Authors:  A E Evans; G J D'Angio; J Randolph
Journal:  Cancer       Date:  1971-02       Impact factor: 6.860

5.  Biologic differences between neuroblastoma stages IV-S and IV. Measurement of serum ferritin and E-rosette inhibition in 30 children.

Authors:  H W Hann; A E Evans; I J Cohen; J E Leitmeyer
Journal:  N Engl J Med       Date:  1981-08-20       Impact factor: 91.245

6.  Clinical evaluation of sequentially scheduled cisplatin and VM26 in neuroblastoma: response and toxicity.

Authors:  F A Hayes; A A Green; J Casper; J Cornet; W E Evans
Journal:  Cancer       Date:  1981-10-15       Impact factor: 6.860

7.  Selective toxicity of 6-hydroxydopamine and ascorbate for human neuroblastoma in vitro: a model for clearing marrow prior to autologous transplant.

Authors:  C P Reynolds; D A Reynolds; E P Frenkel; R G Smith
Journal:  Cancer Res       Date:  1982-04       Impact factor: 12.701

Review 8.  Neuroblastoma: clinical perspectives, monoclonal antibodies, and retinoic acid.

Authors:  R C Seeger; S E Siegel; N Sidell
Journal:  Ann Intern Med       Date:  1982-12       Impact factor: 25.391

9.  High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma.

Authors:  J Pritchard; T J McElwain; J Graham-Pole
Journal:  Br J Cancer       Date:  1982-01       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.